查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1886502

全球防脫髮藥物市場－產業規模、佔有率、趨勢、機會和預測，按類型（產品、藥物）、性別、最終用戶、地區和競爭格局分類，2020-2030年預測

Anti-Hair Loss Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Product, Medicine), By Gender, By End user, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球防脫髮藥物市場規模為28.9億美元，預計到2030年將以8.55%的複合年成長率成長至47.3億美元。該市場涵蓋了旨在緩解脫髮、促進頭髮生長並治療斑禿等疾病的藥物製劑和外用製劑，以及各種醫療程序。市場擴張的主要驅動力是全球不同人群脫髮盛行率的不斷上升，以及人口老化加劇，老年人更容易受到此類問題的困擾。消費者對現有治療方法的認知度提高以及對美觀的日益重視也進一步促進了市場成長。

市場概覽
預測期 2026-2030
市場規模：2024年 28.9億美元
市場規模：2030年 47.3億美元
複合年成長率：2025-2030年 8.55%
成長最快的細分市場 女性
最大的市場 北美洲

主要市場促進因素

脫髮疾病日益普遍，從根本上推動了全球防脫髮藥物市場的需求。諸如雄性禿和斑禿等疾病影響著相當一部分人群，促使人們積極尋求有效的治療方案。

主要市場挑戰

假性脫髮治療產品的氾濫嚴重阻礙了全球防脫髮藥物市場的擴張。這些非法產品通常含有未經批准或有害的成分，直接危害消費者健康，而且往往沒有任何治療效果。

主要市場趨勢

生物療法和再生療法的出現標誌著抗脫髮藥物市場發生了重大變革，其治療重點不再局限於症狀緩解，而是轉向解決潛在的細胞機制。這些先進療法，包括幹細胞療法和基因療法，著重於再生毛囊並恢復頭髮的自然生長週期。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球防脫髮藥物市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（產品、藥品）
    • 按性別（男，女）
    • 依最終使用者分類（皮膚科醫院和診所、家庭護理機構、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美防脫髮藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲防脫髮藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區防脫髮藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲防脫髮藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲防脫髮藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球防脫髮藥物市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Histogen Inc.
  • Aclaris Therapeutics, Inc.
  • Coegin Pharma AB

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22460

The Global Anti-Hair Loss Medicine Market, valued at USD 2.89 Billion in 2024, is projected to experience a CAGR of 8.55% to reach USD 4.73 Billion by 2030. The Global Anti-Hair Loss Medicine Market comprises pharmaceutical and topical formulations, alongside various medical procedures, engineered to mitigate hair fall, stimulate regrowth, and address conditions such as alopecia. Market expansion is primarily propelled by the increasing global prevalence of hair loss across diverse demographics, alongside a burgeoning aging population inherently more susceptible to such concerns. Heightened consumer awareness regarding available treatment modalities and a strong emphasis on aesthetic well-being further contribute to this growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.89 Billion
Market Size 2030USD 4.73 Billion
CAGR 2025-20308.55%
Fastest Growing SegmentFemale
Largest MarketNorth America

Key Market Drivers

The increasing prevalence of hair loss disorders fundamentally drives demand within the global anti-hair loss medicine market. Conditions such as androgenetic alopecia and alopecia areata affect a substantial portion of the population, leading individuals to actively seek effective treatment solutions. According to the National Council on Aging, in April 2025, "30 Interesting Hair Loss Statistics - National Council on Aging", 85% of men and 33% of women will experience some form of hair loss during their lifetimes, underscoring the widespread nature of this concern.

Key Market Challenges

The pervasive issue of counterfeit hair loss treatments poses a significant impediment to the expansion of the Global Anti-Hair Loss Medicine Market. These illicit products frequently contain unapproved or harmful ingredients, directly endangering consumer health and often providing no therapeutic benefit. Such instances compromise patient safety, leading to adverse reactions or ineffective outcomes that erode public confidence in all hair loss solutions.

Key Market Trends

The emergence of biologic and regenerative therapies marks a significant evolution in the anti-hair loss medicine market, moving beyond symptomatic treatments to address underlying cellular mechanisms. These advanced approaches, including stem cell and gene therapies, focus on regenerating hair follicles and restoring natural growth cycles. According to the International Society of Hair Restoration Surgery, in 2024, 84.7% of surgical hair restoration procedures were performed on male patients, compared to 15.3% on female patients, indicating a substantial patient pool seeking effective solutions across genders.

Key Market Players

  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Histogen Inc.
  • Aclaris Therapeutics, Inc.
  • Coegin Pharma AB

Report Scope:

In this report, the Global Anti-Hair Loss Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anti-Hair Loss Medicine Market, By Type:

  • Product
  • Medicine

Anti-Hair Loss Medicine Market, By Gender:

  • Male
  • Female

Anti-Hair Loss Medicine Market, By End user:

  • Dermatology hospitals and clinics
  • Home Care Setting
  • Others

Anti-Hair Loss Medicine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Anti-Hair Loss Medicine Market.

Available Customizations:

Global Anti-Hair Loss Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anti-Hair Loss Medicine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Product, Medicine)
    • 5.2.2. By Gender (Male, Female)
    • 5.2.3. By End user (Dermatology hospitals and clinics, Home Care Setting, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Anti-Hair Loss Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Gender
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Anti-Hair Loss Medicine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Gender
        • 6.3.1.2.3. By End user
    • 6.3.2. Canada Anti-Hair Loss Medicine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Gender
        • 6.3.2.2.3. By End user
    • 6.3.3. Mexico Anti-Hair Loss Medicine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Gender
        • 6.3.3.2.3. By End user

7. Europe Anti-Hair Loss Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Gender
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Anti-Hair Loss Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Gender
        • 7.3.1.2.3. By End user
    • 7.3.2. France Anti-Hair Loss Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Gender
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Anti-Hair Loss Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Gender
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Anti-Hair Loss Medicine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Gender
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Anti-Hair Loss Medicine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Gender
        • 7.3.5.2.3. By End user

8. Asia Pacific Anti-Hair Loss Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Gender
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Anti-Hair Loss Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Gender
        • 8.3.1.2.3. By End user
    • 8.3.2. India Anti-Hair Loss Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Gender
        • 8.3.2.2.3. By End user
    • 8.3.3. Japan Anti-Hair Loss Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Gender
        • 8.3.3.2.3. By End user
    • 8.3.4. South Korea Anti-Hair Loss Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Gender
        • 8.3.4.2.3. By End user
    • 8.3.5. Australia Anti-Hair Loss Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Gender
        • 8.3.5.2.3. By End user

9. Middle East & Africa Anti-Hair Loss Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Gender
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Anti-Hair Loss Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Gender
        • 9.3.1.2.3. By End user
    • 9.3.2. UAE Anti-Hair Loss Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Gender
        • 9.3.2.2.3. By End user
    • 9.3.3. South Africa Anti-Hair Loss Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Gender
        • 9.3.3.2.3. By End user

10. South America Anti-Hair Loss Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Gender
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Anti-Hair Loss Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Gender
        • 10.3.1.2.3. By End user
    • 10.3.2. Colombia Anti-Hair Loss Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Gender
        • 10.3.2.2.3. By End user
    • 10.3.3. Argentina Anti-Hair Loss Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Gender
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Anti-Hair Loss Medicine Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Merck & Co., Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Johnson & Johnson Services, Inc.
  • 15.3. Dr. Reddy's Laboratories Ltd.
  • 15.4. Cipla Limited
  • 15.5. Sun Pharmaceutical Industries Ltd.
  • 15.6. Histogen Inc.
  • 15.7. Aclaris Therapeutics, Inc.
  • 15.8. Coegin Pharma AB

16. Strategic Recommendations

17. About Us & Disclaimer